Integration of drug, protein, and gene delivery systems with regenerative medicine

Drug Delivery and Translational Research
Elizabeth R LordenKam W Leong

Abstract

Regenerative medicine has the potential to drastically change the field of health care from reactive to preventative and restorative. Exciting advances in stem cell biology and cellular reprogramming have fueled the progress of this field. Biochemical cues in the form of small molecule drugs, growth factors, zinc finger protein transcription factors and nucleases, transcription activator-like effector nucleases, monoclonal antibodies, plasmid DNA, aptamers, or RNA interference agents can play an important role to influence stem cell differentiation and the outcome of tissue regeneration. Many of these biochemical factors are fragile and must act intracellularly at the molecular level. They require an effective delivery system, which can take the form of a scaffold (e.g., hydrogels and electrospun fibers), carrier (viral and nonviral), nano- and microparticle, or genetically modified cell. In this review, we will discuss the history and current technologies of drug, protein, and gene delivery in the context of regenerative medicine. Next, we will present case examples of how delivery technologies are being applied to promote angiogenesis in nonhealing wounds or prevent angiogenesis in age related macular degeneration. Finally, w...Continue Reading

References

Mar 1, 1977·Acta Pathologica Et Microbiologica Scandinavica. Section A, Pathology·F Melsen, L Mosekilde
Jul 28, 1970·Journal of Molecular Biology·H O Smith, K W Wilcox
Aug 1, 1995·Proceedings of the National Academy of Sciences of the United States of America·O BoussifJ P Behr
Jun 1, 1996·The Journal of Surgical Research·M D HariawalaJ F Symes
Apr 17, 1997·Nature·W Risau
Mar 18, 2000·The Journal of Biological Chemistry·J S Kang, J S Kim
Apr 26, 2000·Wound Repair and Regeneration : Official Publication of the Wound Healing Society [and] the European Tissue Repair Society·A Desmoulière
Jul 6, 2000·Journal of Biomedical Materials Research·S R SershenJ L West
Oct 18, 2000·The Journal of Clinical Investigation·R R WhiteC P Rusconi
Feb 22, 2001·Journal of Controlled Release : Official Journal of the Controlled Release Society·H Q MaoK W Leong
Feb 6, 2003·Biotechnology and Bioengineering·M TangJ Hubble
Mar 19, 2003·Circulation·Timothy D HenryUNKNOWN VIVA Investigators
Jun 3, 2004·Proceedings of the National Academy of Sciences of the United States of America·Elena NikulinaMarie T Filbin
Jul 17, 2004·Journal of Biomaterials Science. Polymer Edition·Zarana S Patel, Antonios G Mikos
Jul 23, 2004·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Yanlei HaoGuang Chen
Sep 8, 2004·Gynecologic Oncology·Victor BenezraManuel A Penalver
Dec 22, 2004·Human Gene Therapy·Norma B RomeroMichel Fardeau
Dec 31, 2004·The New England Journal of Medicine·Evangelos S GragoudasUNKNOWN VEGF Inhibition Study in Ocular Neovascularization Clinical Trial Group
Apr 19, 2005·Expert Opinion on Biological Therapy·Raymond M SchiffelersGert Storm
Jul 12, 2005·Biomacromolecules·Sing Yian ChewKam W Leong
Sep 8, 2005·Tissue Engineering·Paolo De CoppiShay Soker
Sep 17, 2005·Journal of Controlled Release : Official Journal of the Controlled Release Society·Xiuling XuXiabin Jing
Nov 22, 2005·Expert Opinion on Drug Delivery·Larry R Brown
Mar 7, 2006·Nature Reviews. Drug Discovery·Eugene W M NgAnthony P Adamis
Mar 18, 2006·Journal of Biomedical Materials Research. Part B, Applied Biomaterials·Hongliang JiangKangjie Zhu
Mar 22, 2006·Tissue Engineering·Wafa M Elbjeirami, Jennifer L West
Oct 6, 2006·The New England Journal of Medicine·Philip J RosenfeldUNKNOWN MARINA Study Group
Nov 17, 2006·Nature Chemical Biology·David BumcrotDinah W Y Sah
Dec 28, 2006·Pharmaceutical Research·Ruth R ChenDavid J Mooney
Dec 28, 2006·Biotechnology and Bioengineering·Daniel S Kohane
May 24, 2007·Tissue Engineering·Ramalingam Murugan, Seeram Ramakrishna

❮ Previous
Next ❯

Citations

Jan 13, 2016·Molecular Therapy : the Journal of the American Society of Gene Therapy·Morgan L Maeder, Charles A Gersbach
Jul 26, 2017·Journal of Biomedical Materials Research. Part B, Applied Biomaterials·Lena LarssonRogerio M Castilho
Dec 5, 2017·Current Oral Health Reports·Lena Larsson
Aug 24, 2016·Antimicrobial Agents and Chemotherapy·Tiffany N GroomsJill M Steinbach-Rankins
Jul 15, 2020·Drug Delivery and Translational Research·Mirza Muhammad Faran Ashraf BaigMuhammad Tayyab Ansari
Jun 3, 2015·Advanced Healthcare Materials·Madhumita PatelByeongmoon Jeong
Nov 18, 2018·International Journal of Molecular Sciences·Dominika Hobernik, Matthias Bros
Sep 11, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Vittoria ChimissoCornelia G Palivan
Sep 25, 2020·Journal of Controlled Release : Official Journal of the Controlled Release Society·Kevin Las HerasRosa Maria Hernandez

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.

Antiparasitics

Antiparasitics are medications which are indicated for the treatment of parasitic diseases. Discover the latest research on antiparasitics here.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Related Papers

Molecular Therapy : the Journal of the American Society of Gene Therapy
Michael S HildebrandRichard J H Smith
Journal of Cardiovascular Translational Research
Vincent F M Segers, Richard T Lee
© 2021 Meta ULC. All rights reserved